ETC 6 Meridian Quality Growth ETF (SXQG)
| Assets | $27.11M |
| Expense Ratio | 1.00% |
| PE Ratio | 17.24 |
| Shares Out | 1.25M |
| Dividend (ttm) | $0.02 |
| Dividend Yield | 0.08% |
| Ex-Dividend Date | Dec 27, 2022 |
| Payout Ratio | 1.43% |
| 1-Year Return | -6.41% |
| Volume | 353 |
| Open | 21.77 |
| Previous Close | 21.71 |
| Day's Range | 21.77 - 21.77 |
| 52-Week Low | 18.63 |
| 52-Week High | 24.10 |
| Beta | 1.09 |
| Holdings | 100 |
| Inception Date | May 10, 2021 |
About SXQG
The ETC 6 Meridian Quality Growth ETF (SXQG) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively-managed fund of US-based companies that exhibit high quality and growth characteristics relative to their peers. SXQG was launched on May 10, 2021 and is managed by Exchange Traded Concepts.
Top 10 Holdings
43.42% of assets| Name | Symbol | Weight |
|---|---|---|
| Apple Inc. | AAPL | 5.10% |
| Alphabet Inc. | GOOGL | 4.80% |
| Mastercard Incorporated | MA | 4.67% |
| Merck & Co., Inc. | MRK | 4.44% |
| The Home Depot, Inc. | HD | 4.34% |
| Texas Instruments Incorporated | TXN | 4.32% |
| Adobe Inc. | ADBE | 4.23% |
| Accenture plc | ACN | 3.96% |
| Intuitive Surgical, Inc. | ISRG | 3.85% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.71% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2022 | $0.0101 | Dec 30, 2022 |
| Nov 30, 2022 | $0.0079 | Dec 5, 2022 |
| Jul 30, 2021 | $0.0004 | Aug 4, 2021 |
News
ETF Odds & Ends: Multiple Funds Change Names
Plus, some interesting ETFs launched last week, and some expense ratios saw a range of adjustments.
6 Meridian Expands ETF Lineup with Growth Strategy Fund, ‘SXQG'
On Tuesday, 6 Meridian, a registered investment advisor, announced the expansion of their product lineup with the launch of its newest equity ETF, the 6 Meridian Quality Growth ETF (SXQG), an actively...
6 Meridian Expands ETF Lineup With Launch of New Quality Growth Strategy (“SXQG”)
SXQG is an active strategy designed to offer exposure to stocks exhibiting higher growth metrics based on a proprietary quant screening approach